| NDC Code | 40032-050-19 |
|---|
| Package Description | 438.4 g in 1 BOTTLE (40032-050-19) |
|---|
| Product NDC | 40032-050 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride And Sodium Bicarbonate |
|---|
| Non-Proprietary Name | Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride And Sodium Bicarbonate |
|---|
| Dosage Form | POWDER, FOR SOLUTION |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20090528 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA090019 |
|---|
| Manufacturer | Novel Laboratories, Inc. |
|---|
| Substance Name | POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE |
|---|
| Strength | 420; 11.2; 5.72; 1.48 |
|---|
| Strength Unit | g/438.4g; g/438.4g; g/438.4g; g/438.4g |
|---|
| Pharmacy Classes | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
|---|